New prostate cancer screening option combines existing tests to substantially increase accuracy
CHICAGO–(ENEWSPF)–February 27, 2014. Northwestern Medicine®is the first health care provider in the country to offer a new non-invasive blood test for prostate cancer that is nearly three times more accurate than the current standard prostate-specific antigen (PSA) blood test. Known as the Prostate Health Index (phi), the new test’s accuracy will effectively remove the need for many men who test positive for…
